| scholarly article | Q13442814 |
| P50 | author | Wilfred F J van IJcken | Q47502980 |
| Carla C Baan | Q52855873 | ||
| P2093 | author name string | W Weimar | |
| A P Stubbs | |||
| J N M Ijzermans | |||
| M Pescatori | |||
| M J Hoogduijn | |||
| E Eggenhofer | |||
| M H Dahlke | |||
| M J Crop | |||
| S S Korevaar | |||
| P2860 | cites work | Interferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells | Q24681395 |
| Multilineage potential of adult human mesenchymal stem cells | Q27860737 | ||
| Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
| Human mesenchymal stem cells modulate allogeneic immune cell responses | Q28288692 | ||
| Identifying differentially expressed genes using false discovery rate controlling procedures | Q29615200 | ||
| Human adipose tissue is a source of multipotent stem cells | Q29617385 | ||
| Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli | Q29618769 | ||
| Mesenchymal stem cells as trophic mediators | Q29619806 | ||
| Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression | Q33898626 | ||
| Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. | Q34007524 | ||
| IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease | Q34491107 | ||
| The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. | Q34645189 | ||
| Mesenchymal stem cells: clinical applications and biological characterization. | Q35686355 | ||
| Immunoregulatory function of mesenchymal stem cells | Q36609696 | ||
| Immunological properties of mesenchymal stem cells and clinical implications. | Q37077378 | ||
| Potential of mesenchymal stem cells as immune therapy in solid-organ transplantation | Q37322619 | ||
| Interferon-gamma and tumor necrosis factor-alpha differentially affect cytokine expression and migration properties of mesenchymal stem cells | Q39753209 | ||
| Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate | Q44669692 | ||
| Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation | Q44786842 | ||
| Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells | Q45195471 | ||
| Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6. | Q45946882 | ||
| Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients | Q46081833 | ||
| In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells | Q46566223 | ||
| Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. | Q46670167 | ||
| Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities. | Q51972063 | ||
| Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. | Q52008649 | ||
| Isolation and characterization of multipotent skin-derived precursors from human skin. | Q52048827 | ||
| Human mesenchymal stem cells promote survival of T cells in a quiescent state. | Q52578076 | ||
| Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. | Q54671130 | ||
| A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells | Q56765649 | ||
| Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group | Q57702230 | ||
| Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide | Q61645540 | ||
| Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heart | Q79767911 | ||
| Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells | Q80057941 | ||
| Cell contact interaction between adipose-derived stromal cells and allo-activated T lymphocytes | Q84617890 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 474-486 | |
| P577 | publication date | 2010-09-15 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells | |
| P478 | volume | 162 |
| Q58615746 | Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer |
| Q42204174 | Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile. |
| Q40163992 | Adipose-derived mesenchymal stem cells from infrapatellar fat pad of patients with rheumatoid arthritis and osteoarthritis have comparable immunomodulatory properties. |
| Q37813497 | Adipose-derived stem cells for myocardial infarction |
| Q38352601 | Adipose-derived stem cells in radiotherapy injury: a new frontier |
| Q38028031 | Adipose-derived stromal cells (ASCs). |
| Q34601943 | Adipose-derived stromal cells promote allograft tolerance induction |
| Q27021721 | Adipose-derived stromal/stem cells: a primer |
| Q50490998 | Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. |
| Q38247754 | Application of adipose-derived stem cells in heart disease |
| Q38424008 | Are mesenchymal stromal cells immune cells? |
| Q50047541 | Articular and subcutaneous adipose tissues of rheumatoid arthritis patients represent equal sources of immunoregulatory mesenchymal stem cells. |
| Q34373132 | Autophagy regulates the therapeutic potential of mesenchymal stem cells in experimental autoimmune encephalomyelitis |
| Q43207208 | Canine adipose-derived stromal cell viability following exposure to synovial fluid from osteoarthritic joints |
| Q36391489 | Comparative Analysis of the Immunomodulatory Properties of Equine Adult-Derived Mesenchymal Stem Cells(). |
| Q41761408 | Comparative analysis of human mesenchymal stem cells from fetal-bone marrow, adipose tissue, and Warton's jelly as sources of cell immunomodulatory therapy |
| Q35538801 | Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma |
| Q92454923 | Current Strategies to Enhance Adipose Stem Cell Function: An Update |
| Q93379581 | Cytokinome of adult-derived human liver stem/progenitor cells: immunological and inflammatory features |
| Q34273076 | Different culture conditions modulate the immunological properties of adipose stem cells. |
| Q42012692 | Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells |
| Q33561525 | Effects of Macromolecular Crowding on Human Adipose Stem Cell Culture in Fetal Bovine Serum, Human Serum, and Defined Xeno-Free/Serum-Free Conditions. |
| Q92511363 | Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies |
| Q42057790 | Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis |
| Q38079837 | Evolution and future prospects of adipose-derived immunomodulatory cell therapeutics |
| Q53504545 | Expression of genes involved in immune response and in vitro immunosuppressive effect of equine MSCs. |
| Q44392722 | Features of synergism between mesenchymal stem cells and immunosuppressive drugs in a murine heart transplantation model |
| Q38439453 | Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive In vitro and in a Humanized Allograft Rejection Model. |
| Q39516901 | Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin |
| Q37719212 | Human adipose-derived stromal/stem cells induce functional CD4+CD25+FoxP3+CD127- regulatory T cells under low oxygen culture conditions |
| Q44363859 | Human adipose-tissue derived mesenchymal stem cells induce functional de-novo regulatory T cells with methylated FOXP3 gene DNA. |
| Q24305497 | Human renal tubular epithelial cells suppress alloreactive T cell proliferation |
| Q95411196 | Immune-related antigens, surface molecules and regulatory factors in human-derived mesenchymal stromal cells: the expression and impact of inflammatory priming |
| Q94503661 | Immunomodulatory Effect of Adipose-Derived Stem Cells: The Cutting Edge of Clinical Application |
| Q61818596 | Immunomodulatory Functions of Mesenchymal Stem Cells in Tissue Engineering |
| Q36105639 | Immunomodulatory effect of mesenchymal stem cells on B cells |
| Q42261792 | In Vivo Immunogenic Response to Allogeneic Mesenchymal Stem Cells and the Role of Preactivated Mesenchymal Stem Cells Cotransplanted with Allogeneic Islets. |
| Q64968451 | Insights into Inflammatory Priming of Adipose-Derived Mesenchymal Stem Cells: Validation of Extracellular Vesicles-Embedded miRNA Reference Genes as A Crucial Step for Donor Selection. |
| Q49836130 | Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts |
| Q39142316 | Interactions between mesenchymal stem cells and the immune system |
| Q41530947 | Intra-articular delivery of adipose derived stromal cells attenuates osteoarthritis progression in an experimental rabbit model |
| Q92816537 | Intranasal Administration of Mesenchymal Stem Cells Ameliorates the Abnormal Dopamine Transmission System and Inflammatory Reaction in the R6/2 Mouse Model of Huntington Disease |
| Q33678477 | MMP9 integrates multiple immunoregulatory pathways that discriminate high suppressive activity of human mesenchymal stem cells |
| Q39181848 | Melanomas prevent endothelial cell death under restrictive culture conditions by signaling through AKT and p38 MAPK/ ERK-1/2 cascades |
| Q89449438 | Mesenchymal Stem Cell Mediated Immuno-Modulatory and Anti-Inflammatory Mechanisms in Immune and Allergic Disorders |
| Q26746104 | Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality? |
| Q91695791 | Mesenchymal Stromal Cells Anno 2019: Dawn of the Therapeutic Era? Concise Review |
| Q43140623 | Mesenchymal stem cell therapy in osteoarthritis: advanced tissue repair or intervention with smouldering synovial activation? |
| Q41255321 | Mesenchymal stem cell therapy prevents interstitial fibrosis and tubular atrophy in a rat kidney allograft model |
| Q38078103 | Mesenchymal stem cell-educated macrophages |
| Q37982370 | Mesenchymal stem cells and cardiovascular disease: a bench to bedside roadmap |
| Q26770191 | Mesenchymal stem cells and immunomodulation: current status and future prospects |
| Q41864378 | Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion. |
| Q84370960 | Mesenchymal stem cells derived from adipose tissue are not affected by renal disease |
| Q46948858 | Mesenchymal stem cells inhibit cutaneous radiation-induced fibrosis by suppressing chronic inflammation |
| Q38281388 | Mesenchymal stem cells: mechanisms of potential therapeutic benefit in ARDS and sepsis |
| Q35344810 | Mesenchymal stromal (stem) cells to improve solid organ transplant outcome: lessons from the initial clinical trials |
| Q41763064 | Multiparameter Analysis of Human Bone Marrow Stromal Cells Identifies Distinct Immunomodulatory and Differentiation-Competent Subtypes. |
| Q27316366 | Neuroprotective Potential of Mesenchymal Stem Cell-Based Therapy in Acute Stages of TNBS-Induced Colitis in Guinea-Pigs |
| Q38013107 | On the interactions between mesenchymal stem cells and regulatory T cells for immunomodulation in transplantation |
| Q90351514 | PACT-mediated PKR activation acts as a hyperosmotic stress intensity sensor weakening osmoadaptation and enhancing inflammation |
| Q61443118 | Periodontal Regeneration by Allogeneic Transplantation of Adipose Tissue Derived Multi-Lineage Progenitor Stem Cells in vivo |
| Q64889376 | Perspectives for Clinical Translation of Adipose Stromal/Stem Cells. |
| Q37034680 | Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation |
| Q35927391 | Rat mesenchymal stromal cells inhibit T cell proliferation but not cytokine production through inducible nitric oxide synthase |
| Q28069890 | Secreted trophic factors of mesenchymal stem cells support neurovascular and musculoskeletal therapies |
| Q37068029 | Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma |
| Q84303950 | Stem cells and cell therapies in lung biology and lung diseases |
| Q27006024 | Stem cells: potential and challenges for kidney repair |
| Q51519261 | Suppression of interleukin 17 contributes to the immunomodulatory effects of adipose-derived stem cells in a murine model of systemic lupus erythematosus. |
| Q58567563 | Suppressive effect mediated by human adipose-derived stem cells on T cells involves the activation of JNK |
| Q37570411 | The Effects of Endocrine Disruptors on Adipogenesis and Osteogenesis in Mesenchymal Stem Cells: A Review |
| Q98177880 | The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome |
| Q45913373 | The Immunomodulatory Effects of Mesenchymal Stem Cell Polarization within the Tumor Microenvironment Niche. |
| Q41956444 | The crosstalk between vascular MSCs and inflammatory mediators determines the pro-calcific remodelling of human atherosclerotic aneurysm. |
| Q50986513 | The effect of rabbit antithymocyte globulin on human mesenchymal stem cells. |
| Q46339475 | The effects of human umbilical cord perivascular cells on rat hepatocyte structure and functional polarity. |
| Q91863411 | The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation |
| Q38218112 | The life and fate of mesenchymal stem cells |
| Q33577019 | The neuroprotective effects of human bone marrow mesenchymal stem cells are dose-dependent in TNBS colitis |
| Q36530799 | Tissue-Related Hypoxia Attenuates Proinflammatory Effects of Allogeneic PBMCs on Adipose-Derived Stromal Cells In Vitro |
| Q38616181 | TlR expression profile of human gingival margin-derived stem progenitor cells |
| Q36482258 | Ultraviolet B preconditioning enhances the hair growth-promoting effects of adipose-derived stem cells via generation of reactive oxygen species |
| Q37284607 | Utility of a Mouse Model of Osteoarthritis to Demonstrate Cartilage Protection by IFNγ-Primed Equine Mesenchymal Stem Cells |
| Q47152492 | mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2. |
Search more.